procarbazine
information and resources from the National Cancer Institute
Matulane Sigma Tau Pharms Jul 22 1969
|
|
|
|
news articles
Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not ... 21 Dec 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) is a more intensive regimen that has also been ...
Patients With Unfavorable Risk Hodgkin’s Lymphoma May Not ... Dec 19, 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) is a more intensive regimen which has also been evaluated ...
Schering-Plough uses OMS Technology in new deal Nov 18, 2005
BiopharmaReporter.com, ...brain tumour, Temodar is indicated for use in adult patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine ...
Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not ... 21 Dec 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) is a more intensive regimen that has also been ...
Patients With Unfavorable Risk Hodgkin’s Lymphoma May Not ... Dec 19, 2005
Cancer Consultants (press release), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone) is a more intensive regimen which has also been evaluated ...
Schering-Plough uses OMS Technology in new deal Nov 18, 2005
BiopharmaReporter.com, ...brain tumour, Temodar is indicated for use in adult patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine ...
|
|
